SCHEMBL7501503

SCHEMBL7501503

COc1ccc(-n2ccc(CCC(=O)O)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.53
RXRB P28702 1/20 0.53
RXRG P48443 1/20 0.53
ALDH1A1 P00352 4/20 0.47
MAPT P10636 4/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
GAA P10253 2/20 0.46
GCG P01275 1/20 0.46
HDAC6 Q9UBN7 2/20 0.46
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
FFAR1 O14842 2/20 0.46
KDM4E B2RXH2 3/20 0.45
CYP2C8 P10632 1/20 0.45
CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31587169 0.86 AR (0.47) RXRARXRBRXRGALDH1A1L3MBTL1
SCHEMBL18087490 0.85 CYP2C8 (0.48) RXRARXRBRXRGALDH1A1MAPT
SCHEMBL26781440 0.85 HDAC1 (0.58) HDAC6HDAC3HDAC1HDAC2HDAC10
SCHEMBL15603517 0.82 HDAC3 (0.63) RXRARXRBRXRGMAPTL3MBTL1
SCHEMBL31587382 0.79 AR (0.49) ALDH1A1MAPTL3MBTL1GAAHDAC6
SCHEMBL13920721 0.78 FFAR1 (0.56) FFAR1HCAR2POLB
Benzene SCHEMBL27855758 0.77 HDAC6 (0.43) ALDH1A1MAPTL3MBTL1HDAC6HDAC3
SCHEMBL4548446 0.77 FFAR1 (0.48) RXRARXRBRXRGALDH1A1MAPT
SCHEMBL30922254 0.76 ABCB11 (0.46) ALDH1A1HDAC6KDM4ECYP2C9PTGS1
SCHEMBL7055587 0.75 RPA1 (0.51) ALDH1A1MAPTL3MBTL1GAAHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991625-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 2000-04-12 EP disclosed
WO-1998057937-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 WO disclosed